About Seth Harrison
Seth Harrison is a director and 10% owner at Stoke Therapeutics.
Form D filings name Seth Harrison as a director at Galvanize Therapeutics.
Seth Harrison reports to the SEC as a director or major shareholder of 6 public companies, including Akero Therapeutics (AKRO), HeartWare International (HTWR) and Eledon Pharmaceuticals (ELDN).
Seth Harrison first appears on SEC filings in 2007.
Experience
This experience comes from SEC filings. The years are when the filings name Seth Harrison in the role, so the role may have started earlier or lasted longer.
SI
Stoke Therapeutics, Inc.
Director and 10% owner
2019 – 2026 · Public company (STOK)
AI
Akero Therapeutics, Inc.
Director and 10% owner
2019 – 2025 · Public company (AKRO)
HI
HeartWare International, Inc.
Director and 10% owner
2007 – 2016 · Public company (HTWR)
EI
Eledon Pharmaceuticals, Inc.
Director and 10% owner
2014 – 2016 · Public company (ELDN)
AI
Avalo Therapeutics, Inc.
Director and 10% owner
2015 · Public company (AVTX)
TI
Titan Pharmaceuticals Inc.
10% owner
2013 · Public company (TTNP)
Key Colleagues at Startups
The people Seth Harrison works with at each company, as listed on that company's latest Form D.
Galvanize Therapeutics, Inc. · Form D, Sep 11, 2025
DG
Doug Godshall
Executive officer and director
JW
Jonathan Waldstreicher
Executive officer
AP
Antoine Papiernik
Director
DL
David Lewis
Director
SA
ZS
Zack Scott
Director